Current Treatment Of Chronıc Hepatıtıs C Genotype 1
Hepatitis C virus (HCV) causes both acute and chronic hepatitis. Following acute HCV infection, chronic infection develops in about %80 of patients. In years, Chronic hepatitis C can progress to cirrhosis, hepatocellular carcinoma (HCC) or may result in liver transplantation. It is one of the most c...
Main Authors: | Mesut Aydın, Ahmet Cumhur Dülger |
---|---|
Format: | Article |
Language: | English |
Published: |
Van Yuzuncu Yil University, School of Medicine
2018-10-01
|
Series: | Van Tıp Dergisi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-14890 |
Similar Items
-
Chronic Hepatitis C Treatment with New Antiviral Agents
by: Özlem KANDEMİR
Published: (2018-12-01) -
Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C
by: A. I. Gubenko, et al.
Published: (2023-12-01) -
Distribution of Primary Resistance Mutations in Saint Petersburg in Patients with Chronic Hepatitis C
by: Diana Valutite, et al.
Published: (2022-04-01) -
Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
by: Joo Hyun Oh, et al.
Published: (2022-11-01) -
Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study
by: Mahmoud H. Teaima, et al.
Published: (2021-12-01)